Other potential adverse reactions include hypersensitivity reactions, acute pancreatitis associated with discontinuation of metreleptin, hypoglycemia with concomitant use of insulin and other anti-diabetics, T-cell lymphoma, immunogenicity, and serious and severe infections. Here, INS is linked to acute pancreatitis.